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Background: Oral melanomas have some histopathological resemblance with its cutaneous counterpart; howev-
er, an aggressive behavior is more common in tumors that occur in the oral cavity. Several markers have been 
suggested as indicative of tumoral progression and aggressiveness, such as cyclooxygenase 2 (COX-2) and Ki67.
Material and Methods: In this study, we have compared the expression of COX-2 and Ki67 in a series of amelanot-
ic (n=7) and melanotic oral melanomas (n=22). The cases were selected from 4 pathology laboratories and sub-
mitted to the immunohistochemical (IHC) reactions. We analyzed the IHC staining based on a qualitative – using 
visual scores; and a computer-assisted method (quantitative) using scanned slides and software for digital analysis.
Results: COX-2 was expressed in all oral melanomas; however, its intensity was significantly higher in the amel-
anotic ones (P<0.001). Similarly, a high Ki67-positivity index was observed in the amelanotic than melanotic ones 
(P<0.001). 
Conclusions: Based on these results, we suggest that amelanotic oral melanomas have marked pro-inflammatory 
and high-proliferative phenotype, justifying their more aggressive behavior compared with the melanotic ones.
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Polymer; Dako, Glostrup, Denmark) was applied for 1 
hour. The reaction was developed with Permanent Red 
(Permanent Red Substrate System; Dako) and coun-
terstained with Carazzi hematoxylin. Sections of oral 
squamous cell carcinoma were included in all reactions 
as positive control for both markers. Negative controls 
of reactions were performed by omitting the primary 
antibody. Only cytoplasmic staining was considered 
as positive for COX-2, and only nuclear reactivity was 
considered for Ki67. The quantification of the immuno-
reactivity was determined using a digital method previ-
ously validated by our group (10,13).
Results
Amelanotic melanomas were more common in men 
(5 males, 2 females), with a mean age of 51.5 years. 
The most common location was gingiva (3 cases), fol-
lowed by palate (2 cases), tongue (n=1) and lip (n=1). 
Five patients died from complications of the disease, 1 
lost follow-up and 1 is disease-free. All but one patient 
was treated with surgery and complementary chemo-
therapy.
The conventional melanotic melanomas occurred pre-
dominantly in women (14 females, 8 males), with a 
mean age of 58 years. The locations were palate (n=14), 
gingiva (n=4) and other anatomical sites (n=4). Regard-
ing treatment, 15 were treated with only surgery and 7 
received complementary chemotherapy. Twelve patients 
died from complications of the tumor and 10 are alive.
COX-2 was expressed in the cytoplasm of tumor cells 
and occasionally in inflammatory cells. All melano-
mas were positive for COX-2 in different degrees. In 
the present series COX-2 expression had the highest 
positivity index for amelanotic (scores ranging from 143 
to 294, mean 206), followed by melanotic melanomas 
(scores ranging from 101 to 144, mean 122.5). Repre-
sentative photomicrographs are illustrated in the Fig. 1. 
The means were statistically different (t test, P<0.001).
Ki-67 presented a nuclear expression mainly in tumor 
cells. The index was digitally calculated and were high-
er for amelanotic (ranging from 34 to 92%, mean 64%) 
than melanotic melanomas (ranging from 11 to 59%, 
mean 30.8%). These results are described in the Fig. 2. 
The means were statistically different (t test, P<0.001).
Discussion
To the best of our knowledge this is the first study to 
compare the expression of COX-2 and Ki67 in amela-
notic versus conventional melanotic oral melanomas. In 
the present study we found that both studied markers 
demonstrated higher expression in amelanotic mela-
nomas than melanotic ones. The main theory for these 
results, is that the amelanotic tumors represent a most 
undifferentiated neoplasm, and the presence of melanin 
may represent a more differentiated phenotype.
Introduction
Cutaneous and mucosal melanomas origin from cells 
derivate of the neural crest, the melanocytes (1). Clini-
cally and microscopically, some tumors do not produce 
melanin, a brownish pigment that characterize these 
cells, and are named amelanotic tumors (2). In the cuta-
neous counterpart, the absence of melanin is considered 
a sign of aggressiveness (3). However, in the tumors of 
the oral cavity, the significance of this biological event 
is poorly understood.
Cyclooxygenase 2 (COX-2) is an enzyme involved in 
several inflammatory pathways. Its main function is 
the conversion of arachidonic acid to prostaglandin (4) 
COX-2 mediate several cellular functions, and in the 
context of the cancer, its higher expression is associated 
with modulation of angiogenesis, cellular migration, in-
vasion and proliferation, as well as apoptotic resistance, 
events that favors tumor progression (5). In fact, COX-2 
is associated with aggressiveness in non-small cell lung 
cancer (6), pancreatic ductal adenocarcinoma (7), hepa-
tocellular carcinoma (8) and colorectal cancer (9).
Previous studies of our group have demonstrated that 
COX-2 expression is associated with angiogenesis in 
ameloblastoma (10) and cellular proliferation in cuta-
neous melanomas (11). However, to date, comparative 
studies of oral melanotic and amelanotic melanomas are 
not available in the English language literature. The aim 
of the present study was to evaluate the immunohisto-
chemical expression of COX-2 and Ki67 in oral mela-
notic and amelanotic melanomas.
Material and Methods
Formalin-fixed, paraffin-embedded tissue blocks and 
clinical information of 29 oral melanomas (7 amela-
notic and 22 conventional melanotic) were obtained 
from the charts of four oral pathology laboratories from 
Latin America (Guatemala, Mexico and 2 from Brazil). 
Hematoxylin and eosin–stained slides were used for re-
viewing all diagnoses, and difficult cases were submit-
ted to immunohistochemical analysis (HMB-45, S-100 
and MelanA). To classify the melanomas selected in this 
study, we used a method proposed by Prasad et al. (12).
Accordingly previous protocols used in our laboratory, 
for immunohistochemical staining, 3-µm-thick sec-
tions were deparaffinized, rehydrated in graded ethanol 
solutions and after antigen retrieval with EDTA/Tris 
buffer (pH 9.0) in a pressure cooker; endogenous per-
oxidase activity was blocked with 20% H2O2 during 
15 min. We used a method of 2-hours incubation with 
the primary antibodies: COX-2 (Clone: CX-294, dilu-
tion 1:100; Dako Corporation, Carpinteria, CA, USA) 
and Ki67 (Clone: MIB-1, dilution 1:100; Dako Corpo-
ration). Both diluted in BSA (bovine serum albumin). 
The secondary antibody conjugated with polymer dex-
tran marked with peroxidase (Dako EnVision Labelled 
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Fig. 1: COX-2 expression in amelanotic (A) and melanotic melanomas (B). Graphical representation of the scores of im-
munopositivity.
Fig. 2: Ki67-nuclear expression in amelanotic (A) and melanotic melanomas (B). Graphical representation of the cellular 
proliferative index based on Ki67 expression.
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Other theory is that amelanotic tumors represent a de-
differentiated conventional melanoma. In our opinion, 
it is very difficult to affirm which theory is more ad-
equate. We only can confirm that amelanotic tumors re-
ally present a more aggressive behavior.
Tumor cell proliferation index is widely recognized to 
indicate the degree of aggressiveness of a tumor. In ad-
dition, Ki67-index has been used as prognostic factor 
for several tumors, including breast cancer (14) and 
mucosal melanomas (15). Although our data suggest a 
relationship between COX-2 expression and higher cell 
proliferation, other features must be considered includ-
ing the idea that amelanotic tumors are more undiffer-
entiated, have higher frequency of necrosis and mitosis 
than melanotic melanomas.
In fact, the higher expression of COX-2 in amelanotic 
corroborates with the hypothesis that these tumors have 
a poorer clinical prognosis, once COX-2 is involved in 
several pro-tumorigenic events, including angiogenesis 
(7), cell proliferation and migration (6) and association 
with a metastatic phenotype (11). Additional studies are 
necessary to determine the biological differences be-
tween amelanotic and melanotic oral melanomas.
In the cutaneous melanomas, the absence of melanin is 
an indicator of aggressiveness. Cheung et al. (3) have 
demonstrated that a higher mitotic index in amelanotic 
melanoma correlates with greater nuclear atypia and a 
worse prognosis. Similarly, our results demonstrated 
that oral amelanotic melanomas have a higher Ki67-
index than the pigmented ones.
In summary, amelanotic melanomas had a higher COX-
2 expression and higher cellular proliferative than mela-
notic ones. These data suggest that amelanotic melano-
mas differ from the melanotic subtype and more studies 
are necessary to better understand the role that the ab-
sence of melanin deposition may cause in the tumoral 
biology. It is important to keep in mind that, due to the 
rarity of these neoplasms, the data presented here must 
be interpreted with caution.
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